557 related articles for article (PubMed ID: 33359888)
41. Long-Term Mortality in Patients With Severe Hypercholesterolemia Phenotype From a Racial and Ethnically Diverse US Cohort.
Miles J; Scotti A; Castagna F; Kuno T; Leone PP; Coisne A; Ludwig S; Lavie CJ; Joshi PH; Latib A; Garcia MJ; Rodriguez CJ; Shapiro MD; Virani SS; Slipczuk L
Circulation; 2024 Feb; 149(6):417-426. PubMed ID: 37970713
[TBL] [Abstract][Full Text] [Related]
42. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.
Home PD; Pocock SJ; Beck-Nielsen H; Curtis PS; Gomis R; Hanefeld M; Jones NP; Komajda M; McMurray JJ;
Lancet; 2009 Jun; 373(9681):2125-35. PubMed ID: 19501900
[TBL] [Abstract][Full Text] [Related]
43. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.
Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M;
Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain).
Rodriguez-Poncelas A; Miravet-Jiménez S; Casellas A; Barrot-De La Puente JF; Franch-Nadal J; López-Simarro F; Mata-Cases M; Mundet-Tudurí X
Br J Ophthalmol; 2015 Dec; 99(12):1628-33. PubMed ID: 26089211
[TBL] [Abstract][Full Text] [Related]
46. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
47. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model.
Shinozaki T; Matsuyama Y; Iimuro S; Umegaki H; Sakurai T; Araki A; Ohashi Y; Ito H;
Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():88-102. PubMed ID: 22435944
[TBL] [Abstract][Full Text] [Related]
48. Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR.
Massicotte-Azarniouch D; Kuwornu JP; Carrero JJ; Lam NN; Molnar AO; Zimmerman D; McCallum MK; Garg AX; Sood MM
Am J Kidney Dis; 2018 Feb; 71(2):191-199. PubMed ID: 29153994
[TBL] [Abstract][Full Text] [Related]
49. Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
Okin PM; Devereux RB; Nieminen MS; Jern S; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Dahlöf B;
Circulation; 2006 Jan; 113(1):67-73. PubMed ID: 16365195
[TBL] [Abstract][Full Text] [Related]
50. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial.
Gencer B; Mach F; Murphy SA; De Ferrari GM; Huber K; Lewis BS; Ferreira J; Kurtz CE; Wang H; Honarpour N; Keech AC; Sever PS; Pedersen TR; Sabatine MS; Giugliano RP
JAMA Cardiol; 2020 Aug; 5(8):952-957. PubMed ID: 32432684
[TBL] [Abstract][Full Text] [Related]
52. Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic control.
Alatorre CI; Hoogwerf BJ; Deeg MA; Nelson DR; Hunter TM; Ng WT; Rekhter MD
Curr Med Res Opin; 2018 Feb; 34(2):337-343. PubMed ID: 29065729
[TBL] [Abstract][Full Text] [Related]
53. DIABETIC RETINOPATHY, CLASSIFIED USING THE LESION-AWARE DEEP LEARNING SYSTEM, PREDICTS DIABETIC END-STAGE RENAL DISEASE IN CHINESE PATIENTS.
Zhao L; Ren H; Zhang J; Cao Y; Wang Y; Meng D; Wu Y; Zhang R; Zou Y; Xu H; Li L; Zhang J; Cooper ME; Tong N; Liu F
Endocr Pract; 2020 Apr; 26(4):429-443. PubMed ID: 31968187
[No Abstract] [Full Text] [Related]
54. Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study.
de Simone G; Devereux RB; Roman MJ; Chinali M; Barac A; Panza JA; Lee ET; Galloway JM; Howard BV
Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):285-91. PubMed ID: 21940153
[TBL] [Abstract][Full Text] [Related]
55. Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment.
Suzuki K; Oikawa T; Nochioka K; Miura M; Kasahara S; Sato M; Aoyanagi H; Shiroto T; Takahashi J; Miyata S; Sakata Y; Shimokawa H
Arterioscler Thromb Vasc Biol; 2019 May; 39(5):934-944. PubMed ID: 30866657
[TBL] [Abstract][Full Text] [Related]
56. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
[TBL] [Abstract][Full Text] [Related]
57. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
[TBL] [Abstract][Full Text] [Related]
58. Atrial fibrillation and the risk of myocardial infarction.
Soliman EZ; Safford MM; Muntner P; Khodneva Y; Dawood FZ; Zakai NA; Thacker EL; Judd S; Howard VJ; Howard G; Herrington DM; Cushman M
JAMA Intern Med; 2014 Jan; 174(1):107-14. PubMed ID: 24190540
[TBL] [Abstract][Full Text] [Related]
59. Incidence and risk factors of severe non-proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study.
Sardarinia M; Asgari S; Hizomi Arani R; Eskandari F; Azizi F; Khalili D; Hadaegh F
J Diabetes Investig; 2022 Feb; 13(2):317-327. PubMed ID: 34403198
[TBL] [Abstract][Full Text] [Related]
60. Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.
Bangalore S; Fayyad R; Messerli FH; Laskey R; DeMicco DA; Kastelein JJ; Waters DD
Am J Cardiol; 2017 Feb; 119(3):379-387. PubMed ID: 27939230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
